{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:22:56Z","timestamp":1791926576063,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.xphs.2023.10.035","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T13:33:12Z","timestamp":1698672792000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prediction of Human Pharmacokinetics From Chemical Structure: Combining Mechanistic Modeling with Machine Learning"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8298-5090","authenticated-orcid":false,"given":"Andrea","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-0741","authenticated-orcid":false,"given":"Holger","family":"Diedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-4063","authenticated-orcid":false,"given":"Andreas H.","family":"G\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-5814","authenticated-orcid":false,"given":"Sebastian","family":"Schneckener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2023.10.035_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2020.03.004","article-title":"Improving the accuracy of predicted human pharmacokinetics: lessons learned from the astrazeneca drug pipeline over two decades","volume":"41","author":"Davies","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.xphs.2023.10.035_bib0002","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.2c00040","article-title":"Evaluation of the success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) modeling predictions to inform early drug discovery","author":"Naga","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2023.10.035_bib0003","unstructured":"Chung T.D.Y., Terry D.B., Smith L.H. In vitro and in vivo assessment of ADME and PK properties during lead selection and lead optimization \u2013 guidelines, benchmarks and rules of thumb. In: Markossian S., Grossman A., Brimacombe K., et al., eds.; 2004."},{"issue":"12","key":"10.1016\/j.xphs.2023.10.035_bib0004","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/17460441.2019.1660642","article-title":"Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery","volume":"14","author":"Lucas","year":"2019","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.035_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13318-018-0496-4","article-title":"Evaluation of generic methods to predict human pharmacokinetics using physiologically based pharmacokinetic model for early drug discovery of tyrosine kinase inhibitors","volume":"44","author":"Ren","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.035_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0091270009333209","article-title":"Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches","volume":"49","author":"Hosea","year":"2009","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2023.10.035_bib0007","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/jps.24373","article-title":"Prospective predictions of human pharmacokinetics for eighteen compounds","volume":"104","author":"Zhang","year":"2015","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.035_bib0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1021\/acs.molpharmaceut.0c01009","article-title":"Prediction of oral pharmacokinetics using a combination of in silico descriptors and in vitro ADME properties","volume":"18","author":"Kosugi","year":"2021","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2023.10.035_bib0009","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/dmd.121.000784","article-title":"Application of empirical scalars to enable early prediction of human hepatic clearance using in vitro-in vivo extrapolation in drug discovery: an evaluation of 173 drugs","volume":"50","author":"Jones","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.035_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-200645050-00006","article-title":"A novel strategy for physiologically based predictions of human pharmacokinetics","volume":"45","author":"Jones","year":"2006","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.xphs.2023.10.035_bib0011","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.drudis.2020.07.001","article-title":"Bayer's in silico ADMET platform: a journey of machine learning over the past two decades","volume":"25","author":"G\u00f6ller","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2023.10.035_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2022.107736","article-title":"HybridML: open source platform for hybrid modeling","volume":"160","author":"Merkelbach","year":"2022","journal-title":"Comput Chem Eng"},{"issue":"10","key":"10.1016\/j.xphs.2023.10.035_bib0013","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/aic.690381003","article-title":"A hybrid neural network-first principles approach to process modeling","volume":"38","author":"Psichogios","year":"1992","journal-title":"AIChE J"},{"key":"10.1016\/j.xphs.2023.10.035_bib0014","doi-asserted-by":"crossref","unstructured":"Rackauckas C., Ma Y., Martensen J., et al. Universal differential equations for scientific machine learning.; 2021. http:\/\/arxiv.org\/abs\/2001.04385","DOI":"10.21203\/rs.3.rs-55125\/v1"},{"key":"10.1016\/j.xphs.2023.10.035_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1570-7946(02)80183-3","article-title":"Application of hybrid models in chemical industry","volume":"10","author":"Mogk","year":"2002","journal-title":"Comput Aided Chem Eng"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.035_bib0016","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/acs.jcim.9b00460","article-title":"Prediction of oral bioavailability in rats: transferring insights from in vitro correlations to (deep) machine learning models using in silico model outputs and chemical structure parameters","volume":"59","author":"Schneckener","year":"2019","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.xphs.2023.10.035_bib0017","unstructured":"Reaxys. \u00a9 2023 Elsevier limited. Date accessed: 11\/2020. https:\/\/www.reaxys.com"},{"key":"10.1016\/j.xphs.2023.10.035_bib0018","unstructured":"Cortellis Integrity. \u00a9 2023 Clarivate. Date accessed: 11\/2020. https:\/\/clarivate.com\/cortellis\/integrity-a-cortellis-solution-learning-center\/"},{"key":"10.1016\/j.xphs.2023.10.035_bib0019","unstructured":"Open Systems Pharmacology Suite. \u00a9 2023 Open systems pharmacology community. https:\/\/www.open-systems-pharmacology.org\/"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.035_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1109\/TNNLS.2020.2978386","article-title":"Comprehensive survey on graph neural networks","volume":"32","author":"Wu","year":"2021","journal-title":"iEEE Trans Neural Networks Learn Syst"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.035_bib0021","first-page":"249","article-title":"Deep learning on graphs: a survey","volume":"34","author":"Zhang","year":"2022","journal-title":"IEEE Trans Neural Networks Learn Syst"},{"key":"10.1016\/j.xphs.2023.10.035_bib0022","series-title":"Proceedings of the 34th International Conference on Machine Learning, ICML","first-page":"2053","article-title":"Neural message passing for quantum chemistry","volume":"2017","author":"Gilmer","year":"2017"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.035_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010044","article-title":"Modeling physico-chemical ADMET endpoints with multitask graph convolutional networks","volume":"25","author":"Montanari","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2023.10.035_bib0024","first-page":"2224","article-title":"Convolutional networks on graphs for learning molecular fingerprints","volume":"2015","author":"Duvenaud","year":"2015","journal-title":"Adv Neural Inf Process Syst"},{"key":"10.1016\/j.xphs.2023.10.035_bib0025","series-title":"Deep Learning for the Life Sciences: Applying Deep Learning to Genomics, Microscopy, Drug Discovery, and More","author":"Ramsundar","year":"2019"},{"key":"10.1016\/j.xphs.2023.10.035_bib0026","doi-asserted-by":"crossref","unstructured":"F\u00fchrer F, Gruber A, Diedem H, G\u00f6ller AH, Menz S, Schneckener S. A deep neural network \u2013 mechanistic hybrid model to predict Pharmacokinetics in Rat. 2023. 2310.09167.pdf (arxiv.org).","DOI":"10.21203\/rs.3.rs-3442927\/v1"},{"issue":"10","key":"10.1016\/j.xphs.2023.10.035_bib0027","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1124\/dmd.107.015644","article-title":"Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs","volume":"35","author":"De Buck","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2023.10.035_bib0028","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/jps.22552","article-title":"PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance","volume":"100","author":"Ring","year":"2011","journal-title":"J Pharm Sci"},{"issue":"e148","key":"10.1016\/j.xphs.2023.10.035_bib0029","article-title":"Physiologically based pharmacokinetic modeling and simulation in pediatric drug development","volume":"3","author":"Maharaj","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.xphs.2023.10.035_bib0030","unstructured":"Pipeline Pilot, Version 23.3.0.58, server version 23.1.0.3283; Dassault Systemes BIOVIA Corp: San Diego, CA (2023)."},{"issue":"5","key":"10.1016\/j.xphs.2023.10.035_bib0031","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.035_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-021-00580-6","article-title":"HobPre: accurate prediction of human oral bioavailability for small molecules","volume":"14","author":"Wei","year":"2022","journal-title":"J Cheminform"},{"key":"10.1016\/j.xphs.2023.10.035_bib0033","unstructured":"OSP repository. \u00a9 2023 Open systems pharmacology community. Date accessed: 04\/2022. https:\/\/github.com\/Open-Systems-Pharmacology\/OSP-PBPK-Model-Library"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.035_bib0034","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00228-014-1740-8","article-title":"Between-subject variability: should high be the new normal?","volume":"70","author":"Al-Sallami","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2023.10.035_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26092572","article-title":"Advances in predictions of oral bioavailability of candidate drugs in man with new machine learning methodology","volume":"26","author":"Fagerholm","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.xphs.2023.10.035_bib0036","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1021\/acs.molpharmaceut.1c00718","article-title":"Machine learning models for human in vivo pharmacokinetic parameters with in-house validation","volume":"18","author":"Miljkovi\u0107","year":"2021","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.035_bib0037","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/026119290903700507","article-title":"Physiologically-based pharmacokinetic modelling for the reduction of animal use in the discovery of novel pharmaceuticals","volume":"37","author":"Thomas","year":"2009","journal-title":"ATLA Altern to Lab Anim"},{"issue":"10","key":"10.1016\/j.xphs.2023.10.035_bib0038","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1002\/jps.22554","article-title":"PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets","volume":"100","author":"Poulin","year":"2011","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.035_bib0039","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-022-00735-9","article-title":"Current approaches for predicting human PK for small molecule development candidates: findings from the IQ human PK prediction working group survey","volume":"24","author":"Petersson","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2023.10.035_bib0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejps.2016.10.036","article-title":"IMI \u2013 oral biopharmaceutics tools project \u2013 evaluation of bottom-up PBPK prediction success part 2: an introduction to the simulation exercise and overview of results","volume":"96","author":"Margolskee","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2023.10.035_bib0041","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.jcim.9b00300","article-title":"In silico prediction of human intravenous pharmacokinetic parameters with improved accuracy","volume":"59","author":"Wang","year":"2019","journal-title":"J Chem Inf Model"},{"issue":"7","key":"10.1016\/j.xphs.2023.10.035_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0101638","article-title":"Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing","volume":"9","author":"T\u00f6rnqvist","year":"2014","journal-title":"PLOS One"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:45:56Z","timestamp":1758361556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923004665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0022354923004665"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.10.035","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of Human Pharmacokinetics From Chemical Structure: Combining Mechanistic Modeling with Machine Learning","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}